Clorox (CLX) Misses Q3 EPS by 1c, Updates Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/21/2026
- Nasdaq leads Wall Street gains as SpaceX, Super Micro boost AI sentiment
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
- SpaceX, Tesla shares rise after Musk says committees exploring possible merger
- Brent falls as Iran's president discusses mediation with Pakistani army chief
- Abbott plans to spin off its nutrition unit as a standalone public company
- Alphabet shares drop ahead of earnings next week
- Supermicro raises Q1 FY2027 revenue outlook on AI demand
- Dow outperforms as Wall Street rises, healthcare stocks lead gains
- Crude Inventory Fell 3.06 Million Barrels Last Week - EIA
Clorox Reports Third-Quarter Fiscal Year 2019 Results, Updates Outlook
May 1, 2019 6:30 AM EDTOAKLAND, Calif., May 1, 2019 /PRNewswire/ --Â For its third quarter of fiscal year 2019, which ended March 31, 2019, The Clorox Company (NYSE: CLX) reported sales growth of 2% and a 5% increase in diluted net earnings per share from continuing operations.
"Overall, we executed well against our key strategic priorities in the third quarter, including robust innovation, industry-leading consumer engagement online and cost-justified pricing," said Clorox Chair and CEO Benno Dorer. "Importantly, we were pleased to deliver a second straight quarter of gross margin expansion. Â
"We are also aggressively addressing heightened competitive activity in... More



